Update from Ferring Pharmaceuticals regarding Desmopressin

18 Sep 2023

Ferring Pharmaceuticals have provided updated information regarding the future supply of DesmoSpray® nasal spray, Octim® nasal spray solution and DDAVP® (Desmopressin) intranasal solution

Ferring Pharmaceuticals will discontinue DDAVP Intranasal solution (Nasal Drops) 0.1mg/ml. Key information from the update:

  1. Desmopressin spray will be available next year once they've fixed their packaging and assembly
  2. Desmopressin nasal drops going to be discontinued
  3. Desmopressin tablets still available.

For more information, you can read the update in full.

Any questions please email clinical@endocrinology.org

Share this story